Pinho, J.O.; Ferreira, M.; Coelho, M.; Pinto, S.N.; Aguiar, S.I.; Gaspar, M.M.
Liposomal Rifabutin—A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant Staphylococcus aureus Infections. Pharmaceuticals 2024, 17, 470.
https://doi.org/10.3390/ph17040470
AMA Style
Pinho JO, Ferreira M, Coelho M, Pinto SN, Aguiar SI, Gaspar MM.
Liposomal Rifabutin—A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant Staphylococcus aureus Infections. Pharmaceuticals. 2024; 17(4):470.
https://doi.org/10.3390/ph17040470
Chicago/Turabian Style
Pinho, Jacinta O., Magda Ferreira, Mariana Coelho, Sandra N. Pinto, Sandra I. Aguiar, and Maria Manuela Gaspar.
2024. "Liposomal Rifabutin—A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant Staphylococcus aureus Infections" Pharmaceuticals 17, no. 4: 470.
https://doi.org/10.3390/ph17040470
APA Style
Pinho, J. O., Ferreira, M., Coelho, M., Pinto, S. N., Aguiar, S. I., & Gaspar, M. M.
(2024). Liposomal Rifabutin—A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant Staphylococcus aureus Infections. Pharmaceuticals, 17(4), 470.
https://doi.org/10.3390/ph17040470